5UD-96893-52258 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-22
Registered in v-safe
2021-01-22
Dose 1 — Pfizer-BioNTech
2021-01-22
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-23
Survey response — days 1–6 daily, dose 1
MedDRA: Injection site pain — Feeling: Good

Free text: General muscle soreness at the injection site, but not painful.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-29
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-02-05
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-11
Dose 2 — Pfizer-BioNTech
2021-02-19
Survey response — day 7, dose 2
MedDRA: Fatigue, Injection site pain — Feeling: Good · Fatigue or tiredness

Free text: On the day of and day after I mostly had fatigue and soreness at the injection site. It's also possible that 24-36 hours after my second dose that my antidepressant/anti-anxiety medication had reduced effectiveness, but is currently back to normal.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-25
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-11
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-18
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-15
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-12
Survey response — 6 months, dose 2
MedDRA: Fatigue, Headache, Oropharyngeal pain, Paranasal sinus discomfort, Paranasal sinus hypersecretion, Photosensitivity reaction, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities

Free text: Sinus pressure, sore throat, sinus drainage, runny nose, fatigued, headache, photosensitive

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-02-11
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-22	Pfizer-BioNTech
2	2021-02-11	Pfizer-BioNTech

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-23

Systemic reaction (other): General muscle soreness at the injection site, but not painful.

Release 4 — day 7, dose 2

2021-02-19

Systemic reaction (other): On the day of and day after I mostly had fatigue and soreness at the injection site. It's also possible that 24-36 hours after my second dose that my antidepressant/anti-anxiety medication had reduced effectiveness, but is currently back to normal.

Release 9 — 6 months, dose 2

2021-08-12

Symptoms: Sinus pressure, sore throat, sinus drainage, runny nose, fatigued, headache, photosensitive

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	✓	·	✓
SD	Headache	✓	·	✓
SD	Oropharyngeal pain	✓	·	✓
SD	Paranasal sinus discomfort	✓	·	✓
SD	Paranasal sinus hypersecretion	✓	·	✓
SD	Photosensitivity reaction	✓	·	✓
SD	Rhinorrhoea	✓	·	✓
SRO	Fatigue	✓	✓	✓
SRO	Injection site pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release